Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ocular allergic disease.

A Bhargava1, W B Jackson, S R El-Defrawy

  • 1Department of Ophthalmology, University of Ottawa Eye Institute, Ottawa, Ontario, Canada.

Drugs of Today (Barcelona, Spain : 1998)
|January 27, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementation of BMI field charts for nutritional assessment in adult patients with tuberculosis in Karnataka.

Public health action·2025
Same author

The application of EPSiT in pilonidal sinus disease: an international Delphi consensus study endorsed by the Association of Laparoscopic Surgeons of Great Britain and Ireland (ALSGBI).

Techniques in coloproctology·2025
Same author

Building social equity and person-centred innovation into the end TB response.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2024
Same author

Undernutrition can no longer be an afterthought for global efforts to eliminate TB.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022
Same author

Physical activity recommendations pre and post abdominal wall reconstruction: a scoping review of the evidence.

Hernia : the journal of hernias and abdominal wall surgery·2022
Same author

Is the Management of Rectal Cancer Using a Watch and Wait Approach Feasible, Safe and Effective in a Publicly Funded General Hospital?

Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Same journal

Monoclonal antibodies for treatment of osteoporosis.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Tebentafusp: a novel drug for the treatment of metastatic uveal melanoma.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Sugemalimab, a novel PD-L1 inhibitor for treatment of advanced or metastatic non-small cell lung cancer.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Mitapivat for sickle cell disease and thalassemia.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Cenegermin for the treatment of dry eye disease.

Drugs of today (Barcelona, Spain : 1998)·2023
See all related articles

Ocular allergy, or allergic conjunctivitis, ranges from mild to severe vision-threatening conditions. Treatment involves allergen avoidance, medications like antihistamines and mast cell stabilizers, and in severe cases, topical steroids or cyclosporine.

Area of Science:

  • Ophthalmology
  • Allergology
  • Immunology

Background:

  • Ocular allergy, commonly allergic conjunctivitis, affects the conjunctiva and can involve the cornea, leading to vision-threatening conditions like atopic keratoconjunctivitis.
  • Its pathogenesis involves a complex IgE-mediated mechanism with mast cell degranulation and inflammatory mediator release.

Purpose of the Study:

  • To review the diagnosis and treatment of ocular allergy, encompassing various forms from seasonal allergic conjunctivitis to severe keratoconjunctivitis.
  • To discuss the pharmacological approaches, including antihistamines, mast cell stabilizers, corticosteroids, and cyclosporine.

Main Methods:

  • Diagnosis is primarily clinical, based on patient history and examination.
  • Treatment strategies include conservative measures like allergen avoidance and pharmacotherapy with multiple drug classes.

Related Experiment Videos

Main Results:

  • Antihistamines and mast cell stabilizers (e.g., levocabastine, olopatadine) are effective for mild to moderate cases.
  • Topical steroids are potent but reserved for refractory cases due to side effects; newer agents may reduce intraocular pressure effects.
  • Cyclosporine shows high efficacy and safety for severe forms like vernal and atopic keratoconjunctivitis.

Conclusions:

  • Allergic conjunctivitis management requires a stepwise approach, starting with conservative measures and progressing to targeted pharmacotherapy.
  • Newer agents offer improved efficacy and safety profiles, particularly for severe and refractory ocular allergies.